Youth cannabis use during critical neurodevelopmental periods poses documented risks to cognitive function, motivation, and academic performance. For clinicians treating adolescent patients, understanding these risks is essential for informed counseling and intervention strategies.
The commentary addresses concerns about cannabis use among young athletes and students. Adolescent brains undergo critical development until approximately age 25, with the endocannabinoid system playing key roles in neuroplasticity and cognitive maturation. Regular cannabis use during this period has been associated with attention deficits, memory impairment, and reduced motivation in longitudinal studies. The combination of athletic performance demands and academic requirements makes this population particularly vulnerable to cannabis-related functional impairments.
“I consistently counsel young patients and their families that cannabis use before age 25 carries real neurological risks that we’re still quantifying. The developing brain deserves our most conservative approach.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- What is the clinical relevance rating for this cannabis research?
- Which medical specialties should pay attention to this research?
- How does this research relate to athletic performance?
- Why is neurodevelopment a concern in cannabis research involving youth?
- What makes this cannabis research clinically significant for prevention efforts?
FAQ
What is the clinical relevance rating for this cannabis research?
This study has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the findings represent emerging developments or policy changes that healthcare providers should monitor closely.
Which medical specialties should pay attention to this research?
This research is particularly relevant for adolescent medicine specialists and healthcare providers working with young patients. The findings also have implications for practitioners involved in neurodevelopmental assessments and youth prevention programs.
How does this research relate to athletic performance?
The study includes athletic performance as a key focus area, suggesting the research examines how cannabis use may impact physical performance in young athletes. This information could be valuable for sports medicine practitioners and athletic trainers working with adolescent athletes.
Why is neurodevelopment a concern in cannabis research involving youth?
Cannabis use during adolescence can potentially affect brain development, as the adolescent brain continues developing until the mid-20s. This research likely examines how cannabis exposure might impact cognitive function, learning, and other neurodevelopmental processes in young people.
What makes this cannabis research clinically significant for prevention efforts?
The study’s focus on youth prevention suggests it provides evidence-based insights that can inform prevention strategies and educational programs. Healthcare providers can use these findings to better counsel adolescent patients and their families about cannabis-related risks and benefits.